Genetics Studies

Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection.

Two critically ill COVID-19 patients were treated with a Hemopurifier, which removes mannosylated viruses and exosomes released by activated cells. Both patients tolerated the treatment well. In one patient, removal of exosomes was associated with improved coagulopathy, oxygenation, and clinical recovery. In the second patient, removal of COVID-19 by the Hemopurifier was observed. The Hemopurifier is currently being further investigated in a safety and feasibility study with up to 40 patients in ICU with COVID-19 infection.

Amundson DE et al (2021).
Front Med (Lausanne).
PubMed:
34692735

Genome-Wide Identification of LATERAL ORGAN BOUNDARIES DOMAIN (LBD) Transcription Factors and Screening of Salt Stress Candidates of Rosa rugosa Thunb.

Wang J et al (2021).
Biology (Basel).
PubMed:
34681091